Muse® by Interaxon Raises $9.5M in Series C to Unlock Brain Potential and Revolutionize Health Technology

Muse® by Interaxon Inc. has just raised an impressive US$9.5 million in its latest funding round, marking another exciting milestone for the company as it continues its mission of unlocking the brain and revolutionizing health. Known for pioneering cutting-edge neurotechnology, Muse is dedicated to empowering individuals with tools that help them achieve optimal well-being. The recent capital injection will drive further innovation and expansion in its groundbreaking line of brain-sensing headbands, including state-of-the-art products like the Muse 2 Headband and the Muse S (Gen 2) Headband. Since its inception in 2014 with the launch of the world’s first widely available consumer brain-sensing headband, Muse has consistently pushed the boundaries of EEG technology. Trusted by prestigious institutions such as Harvard, NASA, and The Mayo Clinic, Muse’s devices provide real-time auditory feedback that guides users in meditation, focus training, and non-invasive sleep interventions. The company is also proud of its contribution to scientific research with over 200 published studies and its record-breaking achievement of selling more portable EEG devices than any other system in history, amassing nearly 6 million hours of completed meditation. The fresh funding will be strategically invested in expanding research and development efforts, enhancing user experiences, and scaling the deployment of Muse’s transformative technologies. This initiative not only reaffirms the company’s commitment to innovate at the intersection of neuroscience and technology but also aims to create a robust ecosystem for both amateur meditators and seasoned professionals. As Muse continues to shape the future of brain-centric health technology, this latest round of funding is a testament to the faith investors have in the positive impact of unlocking our brain’s true potential on global well-being.